AICAR アイデンティティ ガイド: アカデシン、ZMP および AMPK 証拠境界
AICAR naming often collapses acadesine, its intracellular phosphorylated metabolite ZMP and an entire AMPK pathway into one label. Reproducible research needs those…
ソースレビューを読む→
Research Topic
代謝・体組成
Incretin receptor agonists are among the most actively studied peptide classes in metabolic research. This group covers single, dual and triple receptor agonists alongside the amylin analogues and lipolytic sequences frequently used with them.
Catalog materials are presented for research use. Analytical methods and lot-document availability vary by material and must be confirmed from the applicable specification and records.
関連商品
カタログ番号
製品
サイズ
Topic knowledge
Source-reviewed reading for metabolic & body composition
Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 1–6 of 16 reviewed articles · Page 1 of 3
糖尿病性多発ニューロパチーにおけるAICAR: 2024マウス研究で判明したこと
A 2024 study reported prevention and reversal of neuropathy measures after experimental AICAR exposure in mouse models of type 1 and type…
ソースレビューを読む→AOD-9604 証拠境界: GH フラグメント生物学、失敗した開発、ロットの同一性
AOD-9604 is a modified growth-hormone fragment developed around a lipolysis hypothesis. Preclinical plausibility and early development do not override the larger null…
ソースレビューを読む→AOD-9604 OPTIONS 研究: 主な結果、無効な結果、および証拠の限界
AOD-9604 progressed beyond animal work into an obesity-development program. FDA’s 2024 review records that the large OPTIONS study did not show statistically…
ソースレビューを読む→MOTS-c 「人間」: ラベルの意味、そして FDA の言うことはまだ欠けている
“Human” in a MOTS-c catalog title ordinarily describes the referenced peptide sequence; it does not mean the material was isolated from a…
ソースレビューを読む→2015 細胞代謝論文の MOTS-c: 細胞、マウス、およびヒトの証拠のギャップ
The paper that introduced MOTS-c combined cell experiments with mouse metabolic models. It is an important discovery record, but the intervention findings…
ソースレビューを読む→Need a peptide for metabolic & body composition research?
If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.